https://www.selleckchem.com/pr....oducts/pyrrolidinedi
ably increased likelihood of subsequent revision surgery in younger age groups. Cite this article Bone Joint J 2021;103-B(3)479-485. The aim of this study was to investigate the hypothesis that a single dose of tranexamic acid (TXA) would reduce blood loss and transfusion rates in elderly patients undergoing surgery for a subcapital or intertrochanteric (IT) fracture of the hip. In this single-centre, randomized controlled trial, elderly patients undergoing surgery for a hip fracture, either hemiarthr
Aimer
Commentaire
Partagez
